Ciprofloxacin (Cipro InhaIe, BAYQ3939)
14019
Phase 1 small_molecule completed
Quick answer
Ciprofloxacin (Cipro InhaIe, BAYQ3939) for Pulmonary Disease, Chronic Obstructive is a Phase 1 program (small_molecule) at Bayer HealthCare AG with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Bayer HealthCare AG
- Indication
- Pulmonary Disease, Chronic Obstructive
- Phase
- Phase 1
- Modality
- small_molecule
- Status
- completed